van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65:3756–88.
Article CAS PubMed Google Scholar
Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265–73.
Article CAS PubMed Google Scholar
Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-Mesenchymal Transitions in Development and Disease. Cell. 2009;139:871–90.
Article CAS PubMed Google Scholar
Hartsock A, Nelson WJ. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta Biomembr. 2008;1778:660–9.
Bajpai S, Correia J, Feng Y, Figueiredo J, Sun SX, Longmore GD, et al. Catenin mediates initial E-cadherin-dependent cell-cell recognition and subsequent bond strengthening. PNAS. 2008;105:18331–6.
Article ADS CAS PubMed PubMed Central Google Scholar
Li CI, Anderson BO, Daling JR, More RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. J Am Med Assoc. 2003;289:1421–4.
Liu JB, Feng CY, Deng M, Ge DF, Liu DC, Mi JQ, et al. E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis. World J Surg Oncol. 2017;15:139.
Article PubMed PubMed Central Google Scholar
Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439–44.
Article ADS CAS PubMed PubMed Central Google Scholar
Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 2013;4:446–62.
Article PubMed PubMed Central Google Scholar
Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin’s dark side: possible role in tumor progression. Biochim Biophys Acta Rev Cancer. 2012;1826:23–31.
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012;486:346–52.
Article CAS PubMed PubMed Central Google Scholar
Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA. 2020;117:5931–7.
Article ADS CAS PubMed PubMed Central Google Scholar
Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004;4:118–32.
Article CAS PubMed Google Scholar
Pece S, Gutkind JS. Signaling from E-cadharins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem. 2000;275:41227–33.
Article CAS PubMed Google Scholar
Kovacs EM, Ali RG, McCormack AJ, Yap AS. E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts. J Biol Chem. 2002;277:6708–18.
Article CAS PubMed Google Scholar
Zantek N, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, Kinch M. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ. 1999;10:629–38.
Fedor-Chaiken M, Hein PW, Stewart JC, Brackenbury R, Kinch MS. E-cadherin binding modulates EGF receptor activation. Cell Communication and Adhes. 2003;10:105–18.
Ramírez Moreno M, Bulgakova NA. The Cross-Talk Between EGFR and E-Cadherin. Front Cell Dev Biol. 2022;9:828673
Article PubMed PubMed Central Google Scholar
Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 1999;59. http://aacrjournals.org/cancerres/article-pdf/59/20/5079/2472940/5079.pdf.
Patil PU, D’Ambrosio J, Inge LJ, Mason RW, Rajasekaran AK. Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR. J Cell Sci. 2015;128:4366–79.
CAS PubMed PubMed Central Google Scholar
Stockinger A, Eger A, Wolf J, Beug H, Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity. J Cell Biol. 2001;154:1185–96.
Article CAS PubMed PubMed Central Google Scholar
Soler C, Grangeasse C, Baggetto LG, Damour O. Dermal fibroblast proliferation is improved by β-catenin overexpression and inhibited by E-cadherin expression. FEBS Lett. 1999;442:178–82.
Article CAS PubMed Google Scholar
Heibeck TH, Ding SJ, Opresko LK, Zhao R, Schepmoes AA, Yang F, et al. An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells. J Proteome Res. 2009;8:3852–61.
Article CAS PubMed PubMed Central Google Scholar
Lee MH, Russo GC, Rahmanto YS, Du W, Crawford AJ, Wu PH, et al. Multi-compartment tumor organoids. Mater Today. 2022;61:104–16.
Crawford AJ, Forjaz A, Bhorkar I, Roy T, Schell D, Queiroga V, et al. Precision-engineered biomimetics: the human fallopian tube. bioRxiv. 2023. https://doi.org/10.1101/2023.06.06.543923.
Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and Its relevance with breast tumor subtyping. J Cancer. 2017;8:3131–41.
Article PubMed PubMed Central Google Scholar
Liu K, Newbury PA, Glicksberg BS, Zeng WZD, Paithankar S, Andrechek ER, et al. Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data. Nat Commun. 2019;10:2138.
Article ADS CAS PubMed PubMed Central Google Scholar
Wu PH, Gilkes DM, Phillip JM, Narkar A, Cheng TWT, Marchand J, et al. Single-cell morphology encodes metastatic potential. Sci Adv. 2020;6:eaaw6938.
Article ADS CAS PubMed PubMed Central Google Scholar
Sonnaert M, Papantoniou I, Luyten FP, Schrooten J. Quantitative validation of the Presto BlueTM metabolic assay for online monitoring of cell proliferation in a 3D perfusion bioreactor system. Tissue Eng Part C Methods. 2015;21:519–29.
Article CAS PubMed PubMed Central Google Scholar
Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279–90.
Article CAS PubMed Google Scholar
Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4:9.
Barrett SD, Bridges AJ, Dudley DT, Saltiel AR, Fergus JH, Flamme CM, et al. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg Med Chem Lett. 2008;18:6501–4.
Article CAS PubMed Google Scholar
Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, et al. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and hodgkin lymphoma cells and human xenograft models. Clin Cancer Res. 2014;20:6023–33.
Article CAS PubMed PubMed Central Google Scholar
Wright CJM, McCormack PL. Trametinib: first global approval. Drugs 2013;73:1245–54.
Paulo JA, Mcallister FE, Everley RA, Beausoleil SA, Banks AS, Gygi SP. Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics. Proteomics 2015;15:462–73.
Article CAS PubMed Google Scholar
Bajpai S, Feng Y, Wirtz D, Longmore GD. β-Catenin serves as a clutch between low and high intercellular E-cadherin bond strengths. Biophys J. 2013;105:2289–300.
Article CAS PubMed PubMed Central Google Scholar
Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D, et al. A new mouse model for the study of human breast cancer metastasis. PLoS ONE. 2012;7:e47995.
Article ADS CAS PubMed PubMed Central Google Scholar
Kim Y, Williams KC, Gavin CT, Jardine E, Chambers AF, Leong HS. Quantification of cancer cell extravasation in vivo. Nat Protoc. 2016;11:937–48.
Article CAS PubMed Google Scholar
Chaturvedi P, Gilkes DM, Wong CCL, Kshitiz, Luo W, Zhang H, et al. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Investig. 2013;123:189–205.
留言 (0)